APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Modified Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Modified Proteomics Service Market Analysis and Forecast 2026-2032

12 August 2026191 pages

Choose your research edition.

Industry ResearchModified Proteomics Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Modified Proteomics Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Modified Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modified Proteomics Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Modified Proteomics Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Modified Proteomics Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Modified Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Modified Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Modified Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Modified Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Modified Proteomics Service include BGI Genomics, OmicScouts (Momentum Biotechnologies), Biodesix, Shanghai OE Biotech, Crown Bioscience, Shanghai Bioprofile, Creative Proteomics, Inotiv and MtoZ-Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Modified Proteomics Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Modified Proteomics Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Modified Proteomics Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Modified Proteomics Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Modified Proteomics Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Modified Proteomics Service revenue, projected growth trends, production technology, application and end-user industry.

Modified Proteomics Service Segment by Company

BGI Genomics

OmicScouts (Momentum Biotechnologies)

Biodesix

Shanghai OE Biotech

Crown Bioscience

Shanghai Bioprofile

Creative Proteomics

Inotiv

MtoZ-Biolabs

CellCarta

Biognosys

MS Bioworks

Charles River Laboratories

Metware Biotechnology

Novogene

Evotec

RxCelerate

Shanghai Majorbio Bio-Pharm

Lc-Bio Technologies

CD Genomics

Discovery Life Sciences

Applied Biomics

VProteomics

Allumiqs

Westlake Omics

CDI Labs

Proteome Sciences

Sapient Bioanalytics

Proteomics International

Cosmos Wisdom

MRM Proteomics

Sinotech Genomics

Precision Biomarker Laboratories (PBL)

PTM BIO

Cell Signaling Technology (CST)

APTBIO

Modified Proteomics Service Segment by Type

Phosphorylation

Acetylation

Ubiquitination

Methylation

Glycosylation

Lactylation

Redox

Palmitoylation

Others

Modified Proteomics Service Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Modified Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modified Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modified Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modified Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Modified Proteomics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Modified Proteomics Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Modified Proteomics Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Modified Proteomics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Phosphorylation Major Player Table 3. Acetylation Major Player Table 4. Ubiquitination Major Player Table 5. Methylation Major Player Table 6. Glycosylation Major Player Table 7. Lactylation Major Player Table 8. Redox Major Player Table 9. Palmitoylation Major Player Table 10. Others Major Player Table 11. Global Modified Proteomics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Clinical Diagnostics Major Player Table 13. Drug Discovery Major Player Table 14. Others Major Player Table 15. Modified Proteomics Service Industry Trends Table 16. Modified Proteomics Service Industry Drivers Table 17. Modified Proteomics Service Industry Opportunities and Challenges Table 18. Modified Proteomics Service Industry Restraints Table 19. Global Modified Proteomics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Modified Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Modified Proteomics Service Market Share by Region (2021-2026) Table 22. Global Modified Proteomics Service Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Modified Proteomics Service Market Share by Region (2027-2032) Table 24. Global Modified Proteomics Service Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Modified Proteomics Service Revenue Market Share by Players (2021-2026) Table 26. Global Modified Proteomics Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Modified Proteomics Service Key Players Headquarters & Area Served Table 28. Global Modified Proteomics Service Players, Product Type & Application Table 29. Global Modified Proteomics Service Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Modified Proteomics Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Modified Proteomics Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Modified Proteomics Service Revenue Market Share by Type (2021-2026) Table 36. Global Modified Proteomics Service Revenue Market Share by Type (2027-2032) Table 37. Global Modified Proteomics Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Modified Proteomics Service Revenue Market Share by Application (2021-2026) Table 41. Global Modified Proteomics Service Revenue Market Share by Application (2027-2032) Table 42. BGI Genomics Company Information Table 43. BGI Genomics Business Overview Table 44. BGI Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BGI Genomics Modified Proteomics Service Product Portfolio Table 46. BGI Genomics Recent Development Table 47. OmicScouts (Momentum Biotechnologies) Company Information Table 48. OmicScouts (Momentum Biotechnologies) Business Overview Table 49. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio Table 51. OmicScouts (Momentum Biotechnologies) Recent Development Table 52. Biodesix Company Information Table 53. Biodesix Business Overview Table 54. Biodesix Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Biodesix Modified Proteomics Service Product Portfolio Table 56. Biodesix Recent Development Table 57. Shanghai OE Biotech Company Information Table 58. Shanghai OE Biotech Business Overview Table 59. Shanghai OE Biotech Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Shanghai OE Biotech Modified Proteomics Service Product Portfolio Table 61. Shanghai OE Biotech Recent Development Table 62. Crown Bioscience Company Information Table 63. Crown Bioscience Business Overview Table 64. Crown Bioscience Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Crown Bioscience Modified Proteomics Service Product Portfolio Table 66. Crown Bioscience Recent Development Table 67. Shanghai Bioprofile Company Information Table 68. Shanghai Bioprofile Business Overview Table 69. Shanghai Bioprofile Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Shanghai Bioprofile Modified Proteomics Service Product Portfolio Table 71. Shanghai Bioprofile Recent Development Table 72. Creative Proteomics Company Information Table 73. Creative Proteomics Business Overview Table 74. Creative Proteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Creative Proteomics Modified Proteomics Service Product Portfolio Table 76. Creative Proteomics Recent Development Table 77. Inotiv Company Information Table 78. Inotiv Business Overview Table 79. Inotiv Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Inotiv Modified Proteomics Service Product Portfolio Table 81. Inotiv Recent Development Table 82. MtoZ-Biolabs Company Information Table 83. MtoZ-Biolabs Business Overview Table 84. MtoZ-Biolabs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. MtoZ-Biolabs Modified Proteomics Service Product Portfolio Table 86. MtoZ-Biolabs Recent Development Table 87. CellCarta Company Information Table 88. CellCarta Business Overview Table 89. CellCarta Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. CellCarta Modified Proteomics Service Product Portfolio Table 91. CellCarta Recent Development Table 92. Biognosys Company Information Table 93. Biognosys Business Overview Table 94. Biognosys Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Biognosys Modified Proteomics Service Product Portfolio Table 96. Biognosys Recent Development Table 97. MS Bioworks Company Information Table 98. MS Bioworks Business Overview Table 99. MS Bioworks Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. MS Bioworks Modified Proteomics Service Product Portfolio Table 101. MS Bioworks Recent Development Table 102. Charles River Laboratories Company Information Table 103. Charles River Laboratories Business Overview Table 104. Charles River Laboratories Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Charles River Laboratories Modified Proteomics Service Product Portfolio Table 106. Charles River Laboratories Recent Development Table 107. Metware Biotechnology Company Information Table 108. Metware Biotechnology Business Overview Table 109. Metware Biotechnology Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Metware Biotechnology Modified Proteomics Service Product Portfolio Table 111. Metware Biotechnology Recent Development Table 112. Novogene Company Information Table 113. Novogene Business Overview Table 114. Novogene Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Novogene Modified Proteomics Service Product Portfolio Table 116. Novogene Recent Development Table 117. Evotec Company Information Table 118. Evotec Business Overview Table 119. Evotec Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Evotec Modified Proteomics Service Product Portfolio Table 121. Evotec Recent Development Table 122. RxCelerate Company Information Table 123. RxCelerate Business Overview Table 124. RxCelerate Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. RxCelerate Modified Proteomics Service Product Portfolio Table 126. RxCelerate Recent Development Table 127. Shanghai Majorbio Bio-Pharm Company Information Table 128. Shanghai Majorbio Bio-Pharm Business Overview Table 129. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio Table 131. Shanghai Majorbio Bio-Pharm Recent Development Table 132. Lc-Bio Technologies Company Information Table 133. Lc-Bio Technologies Business Overview Table 134. Lc-Bio Technologies Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Lc-Bio Technologies Modified Proteomics Service Product Portfolio Table 136. Lc-Bio Technologies Recent Development Table 137. CD Genomics Company Information Table 138. CD Genomics Business Overview Table 139. CD Genomics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. CD Genomics Modified Proteomics Service Product Portfolio Table 141. CD Genomics Recent Development Table 142. Discovery Life Sciences Company Information Table 143. Discovery Life Sciences Business Overview Table 144. Discovery Life Sciences Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Discovery Life Sciences Modified Proteomics Service Product Portfolio Table 146. Discovery Life Sciences Recent Development Table 147. Applied Biomics Company Information Table 148. Applied Biomics Business Overview Table 149. Applied Biomics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Applied Biomics Modified Proteomics Service Product Portfolio Table 151. Applied Biomics Recent Development Table 152. VProteomics Company Information Table 153. VProteomics Business Overview Table 154. VProteomics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. VProteomics Modified Proteomics Service Product Portfolio Table 156. VProteomics Recent Development Table 157. Allumiqs Company Information Table 158. Allumiqs Business Overview Table 159. Allumiqs Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Allumiqs Modified Proteomics Service Product Portfolio Table 161. Allumiqs Recent Development Table 162. Westlake Omics Company Information Table 163. Westlake Omics Business Overview Table 164. Westlake Omics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Westlake Omics Modified Proteomics Service Product Portfolio Table 166. Westlake Omics Recent Development Table 167. CDI Labs Company Information Table 168. CDI Labs Business Overview Table 169. CDI Labs Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. CDI Labs Modified Proteomics Service Product Portfolio Table 171. CDI Labs Recent Development Table 172. Proteome Sciences Company Information Table 173. Proteome Sciences Business Overview Table 174. Proteome Sciences Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Proteome Sciences Modified Proteomics Service Product Portfolio Table 176. Proteome Sciences Recent Development Table 177. Sapient Bioanalytics Company Information Table 178. Sapient Bioanalytics Business Overview Table 179. Sapient Bioanalytics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Sapient Bioanalytics Modified Proteomics Service Product Portfolio Table 181. Sapient Bioanalytics Recent Development Table 182. Proteomics International Company Information Table 183. Proteomics International Business Overview Table 184. Proteomics International Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Proteomics International Modified Proteomics Service Product Portfolio Table 186. Proteomics International Recent Development Table 187. Cosmos Wisdom Company Information Table 188. Cosmos Wisdom Business Overview Table 189. Cosmos Wisdom Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Cosmos Wisdom Modified Proteomics Service Product Portfolio Table 191. Cosmos Wisdom Recent Development Table 192. MRM Proteomics Company Information Table 193. MRM Proteomics Business Overview Table 194. MRM Proteomics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. MRM Proteomics Modified Proteomics Service Product Portfolio Table 196. MRM Proteomics Recent Development Table 197. Sinotech Genomics Company Information Table 198. Sinotech Genomics Business Overview Table 199. Sinotech Genomics Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Sinotech Genomics Modified Proteomics Service Product Portfolio Table 201. Sinotech Genomics Recent Development Table 202. Precision Biomarker Laboratories (PBL) Company Information Table 203. Precision Biomarker Laboratories (PBL) Business Overview Table 204. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio Table 206. Precision Biomarker Laboratories (PBL) Recent Development Table 207. PTM BIO Company Information Table 208. PTM BIO Business Overview Table 209. PTM BIO Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. PTM BIO Modified Proteomics Service Product Portfolio Table 211. PTM BIO Recent Development Table 212. Cell Signaling Technology (CST) Company Information Table 213. Cell Signaling Technology (CST) Business Overview Table 214. Cell Signaling Technology (CST) Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio Table 216. Cell Signaling Technology (CST) Recent Development Table 217. APTBIO Company Information Table 218. APTBIO Business Overview Table 219. APTBIO Modified Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 220. APTBIO Modified Proteomics Service Product Portfolio Table 221. APTBIO Recent Development Table 222. North America Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 223. North America Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 224. North America Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 225. North America Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 226. North America Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. North America Modified Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 228. North America Modified Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 229. Europe Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 230. Europe Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 231. Europe Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 232. Europe Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 233. Europe Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. Europe Modified Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 235. Europe Modified Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 236. China Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 237. China Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 238. China Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 239. China Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 240. Asia Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 241. Asia Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 242. Asia Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 243. Asia Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 244. Asia Modified Proteomics Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Asia Modified Proteomics Service Revenue by Region (US$ Million) & (2021-2026) Table 246. Asia Modified Proteomics Service Revenue by Region (US$ Million) & (2027-2032) Table 247. SAMEA Modified Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 248. SAMEA Modified Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 249. SAMEA Modified Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 250. SAMEA Modified Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 251. SAMEA Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Modified Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 253. SAMEA Modified Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Modified Proteomics Service Image Figure 2. Global Modified Proteomics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modified Proteomics Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Phosphorylation Image Figure 5. Acetylation Image Figure 6. Ubiquitination Image Figure 7. Methylation Image Figure 8. Glycosylation Image Figure 9. Lactylation Image Figure 10. Redox Image Figure 11. Palmitoylation Image Figure 12. Others Image Figure 13. Global Modified Proteomics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Modified Proteomics Service Market Size Share 2021 VS 2025 VS 2032 Figure 15. Clinical Diagnostics Image Figure 16. Drug Discovery Image Figure 17. Others Image Figure 18. Global Modified Proteomics Service Market Size (US$ Million) & (2021-2032) Figure 19. Global Modified Proteomics Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Modified Proteomics Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Modified Proteomics Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Modified Proteomics Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Modified Proteomics Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Modified Proteomics Service Revenue Market Share by Type (2021-2032) Figure 26. Global Modified Proteomics Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Modified Proteomics Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Modified Proteomics Service Revenue Market Share by Application (2021-2032) Figure 29. North America Modified Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Modified Proteomics Service Revenue Share by Type (2021-2032) Figure 31. North America Modified Proteomics Service Revenue Share by Application (2021-2032) Figure 32. North America Modified Proteomics Service Revenue Share by Country (2021-2032) Figure 33. United States Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Modified Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Modified Proteomics Service Revenue Share by Type (2021-2032) Figure 38. Europe Modified Proteomics Service Revenue Share by Application (2021-2032) Figure 39. Europe Modified Proteomics Service Revenue Share by Country (2021-2032) Figure 40. Germany Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Modified Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Modified Proteomics Service Revenue Share by Type (2021-2032) Figure 50. China Modified Proteomics Service Revenue Share by Application (2021-2032) Figure 51. Asia Modified Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Modified Proteomics Service Revenue Share by Type (2021-2032) Figure 53. Asia Modified Proteomics Service Revenue Share by Application (2021-2032) Figure 54. Asia Modified Proteomics Service Revenue Share by Region (2021-2032) Figure 55. Japan Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Modified Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Modified Proteomics Service Revenue Share by Type (2021-2032) Figure 63. SAMEA Modified Proteomics Service Revenue Share by Application (2021-2032) Figure 64. SAMEA Modified Proteomics Service Revenue Share by Country (2021-2032) Figure 65. Brazil Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Modified Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Phosphorylation
  • Acetylation
  • Ubiquitination
  • Methylation
  • Glycosylation
  • Lactylation
  • Redox
  • Palmitoylation
  • Others
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • BGI Genomics
  • OmicScouts (Momentum Biotechnologies)
  • Biodesix
  • Shanghai OE Biotech
  • Crown Bioscience
  • Shanghai Bioprofile
  • Creative Proteomics
  • Inotiv
  • MtoZ-Biolabs
  • CellCarta
  • Biognosys
  • MS Bioworks
  • Charles River Laboratories
  • Metware Biotechnology
  • Novogene
  • Evotec
  • RxCelerate
  • Shanghai Majorbio Bio-Pharm
  • Lc-Bio Technologies
  • CD Genomics
  • Discovery Life Sciences
  • Applied Biomics
  • VProteomics
  • Allumiqs
  • Westlake Omics
  • CDI Labs
  • Proteome Sciences
  • Sapient Bioanalytics
  • Proteomics International
  • Cosmos Wisdom
  • MRM Proteomics
  • Sinotech Genomics
  • Precision Biomarker Laboratories (PBL)
  • PTM BIO
  • Cell Signaling Technology (CST)
  • APTBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Modified Proteomics Service Market by Type
  3. 1.2.1 Global Modified Proteomics Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Phosphorylation
  5. 1.2.3 Acetylation
  6. 1.2.4 Ubiquitination
  7. 1.2.5 Methylation
  8. 1.2.6 Glycosylation
  9. 1.2.7 Lactylation
  10. 1.2.8 Redox
  11. 1.2.9 Palmitoylation
  12. 1.2.10 Others
  13. 1.3 Modified Proteomics Service Market by Application
  14. 1.3.1 Global Modified Proteomics Service Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Clinical Diagnostics
  16. 1.3.3 Drug Discovery
  17. 1.3.4 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Modified Proteomics Service Market Dynamics
  1. 2.1 Modified Proteomics Service Industry Trends
  2. 2.2 Modified Proteomics Service Industry Drivers
  3. 2.3 Modified Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Modified Proteomics Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Modified Proteomics Service Market Perspective (2021-2032)
  2. 3.2 Global Modified Proteomics Service Growth Trends by Region
  3. 3.2.1 Global Modified Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Modified Proteomics Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Modified Proteomics Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Modified Proteomics Service Revenue by Players
  2. 4.1.1 Global Modified Proteomics Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Modified Proteomics Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Modified Proteomics Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Modified Proteomics Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Modified Proteomics Service Key Players Headquarters & Area Served
  7. 4.4 Global Modified Proteomics Service Players, Product Type & Application
  8. 4.5 Global Modified Proteomics Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Modified Proteomics Service Market CR5 and HHI
  11. 4.6.3 2025 Modified Proteomics Service Tier 1, Tier 2, and Tier 3
5 Modified Proteomics Service Market Size by Type
  1. 5.1 Global Modified Proteomics Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Modified Proteomics Service Revenue by Type (2021-2032)
  3. 5.3 Global Modified Proteomics Service Revenue Market Share by Type (2021-2032)
6 Modified Proteomics Service Market Size by Application
  1. 6.1 Global Modified Proteomics Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Modified Proteomics Service Revenue by Application (2021-2032)
  3. 6.3 Global Modified Proteomics Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BGI Genomics
  2. 7.1.1 BGI Genomics Company Information
  3. 7.1.2 BGI Genomics Business Overview
  4. 7.1.3 BGI Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BGI Genomics Modified Proteomics Service Product Portfolio
  6. 7.1.5 BGI Genomics Recent Developments
  7. 7.2 OmicScouts (Momentum Biotechnologies)
  8. 7.2.1 OmicScouts (Momentum Biotechnologies) Company Information
  9. 7.2.2 OmicScouts (Momentum Biotechnologies) Business Overview
  10. 7.2.3 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio
  12. 7.2.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  13. 7.3 Biodesix
  14. 7.3.1 Biodesix Company Information
  15. 7.3.2 Biodesix Business Overview
  16. 7.3.3 Biodesix Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Biodesix Modified Proteomics Service Product Portfolio
  18. 7.3.5 Biodesix Recent Developments
  19. 7.4 Shanghai OE Biotech
  20. 7.4.1 Shanghai OE Biotech Company Information
  21. 7.4.2 Shanghai OE Biotech Business Overview
  22. 7.4.3 Shanghai OE Biotech Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai OE Biotech Modified Proteomics Service Product Portfolio
  24. 7.4.5 Shanghai OE Biotech Recent Developments
  25. 7.5 Crown Bioscience
  26. 7.5.1 Crown Bioscience Company Information
  27. 7.5.2 Crown Bioscience Business Overview
  28. 7.5.3 Crown Bioscience Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Crown Bioscience Modified Proteomics Service Product Portfolio
  30. 7.5.5 Crown Bioscience Recent Developments
  31. 7.6 Shanghai Bioprofile
  32. 7.6.1 Shanghai Bioprofile Company Information
  33. 7.6.2 Shanghai Bioprofile Business Overview
  34. 7.6.3 Shanghai Bioprofile Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Bioprofile Modified Proteomics Service Product Portfolio
  36. 7.6.5 Shanghai Bioprofile Recent Developments
  37. 7.7 Creative Proteomics
  38. 7.7.1 Creative Proteomics Company Information
  39. 7.7.2 Creative Proteomics Business Overview
  40. 7.7.3 Creative Proteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Proteomics Modified Proteomics Service Product Portfolio
  42. 7.7.5 Creative Proteomics Recent Developments
  43. 7.8 Inotiv
  44. 7.8.1 Inotiv Company Information
  45. 7.8.2 Inotiv Business Overview
  46. 7.8.3 Inotiv Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Inotiv Modified Proteomics Service Product Portfolio
  48. 7.8.5 Inotiv Recent Developments
  49. 7.9 MtoZ-Biolabs
  50. 7.9.1 MtoZ-Biolabs Company Information
  51. 7.9.2 MtoZ-Biolabs Business Overview
  52. 7.9.3 MtoZ-Biolabs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MtoZ-Biolabs Modified Proteomics Service Product Portfolio
  54. 7.9.5 MtoZ-Biolabs Recent Developments
  55. 7.10 CellCarta
  56. 7.10.1 CellCarta Company Information
  57. 7.10.2 CellCarta Business Overview
  58. 7.10.3 CellCarta Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CellCarta Modified Proteomics Service Product Portfolio
  60. 7.10.5 CellCarta Recent Developments
  61. 7.11 Biognosys
  62. 7.11.1 Biognosys Company Information
  63. 7.11.2 Biognosys Business Overview
  64. 7.11.3 Biognosys Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Biognosys Modified Proteomics Service Product Portfolio
  66. 7.11.5 Biognosys Recent Developments
  67. 7.12 MS Bioworks
  68. 7.12.1 MS Bioworks Company Information
  69. 7.12.2 MS Bioworks Business Overview
  70. 7.12.3 MS Bioworks Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 MS Bioworks Modified Proteomics Service Product Portfolio
  72. 7.12.5 MS Bioworks Recent Developments
  73. 7.13 Charles River Laboratories
  74. 7.13.1 Charles River Laboratories Company Information
  75. 7.13.2 Charles River Laboratories Business Overview
  76. 7.13.3 Charles River Laboratories Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Charles River Laboratories Modified Proteomics Service Product Portfolio
  78. 7.13.5 Charles River Laboratories Recent Developments
  79. 7.14 Metware Biotechnology
  80. 7.14.1 Metware Biotechnology Company Information
  81. 7.14.2 Metware Biotechnology Business Overview
  82. 7.14.3 Metware Biotechnology Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Metware Biotechnology Modified Proteomics Service Product Portfolio
  84. 7.14.5 Metware Biotechnology Recent Developments
  85. 7.15 Novogene
  86. 7.15.1 Novogene Company Information
  87. 7.15.2 Novogene Business Overview
  88. 7.15.3 Novogene Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Novogene Modified Proteomics Service Product Portfolio
  90. 7.15.5 Novogene Recent Developments
  91. 7.16 Evotec
  92. 7.16.1 Evotec Company Information
  93. 7.16.2 Evotec Business Overview
  94. 7.16.3 Evotec Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Evotec Modified Proteomics Service Product Portfolio
  96. 7.16.5 Evotec Recent Developments
  97. 7.17 RxCelerate
  98. 7.17.1 RxCelerate Company Information
  99. 7.17.2 RxCelerate Business Overview
  100. 7.17.3 RxCelerate Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 RxCelerate Modified Proteomics Service Product Portfolio
  102. 7.17.5 RxCelerate Recent Developments
  103. 7.18 Shanghai Majorbio Bio-Pharm
  104. 7.18.1 Shanghai Majorbio Bio-Pharm Company Information
  105. 7.18.2 Shanghai Majorbio Bio-Pharm Business Overview
  106. 7.18.3 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio
  108. 7.18.5 Shanghai Majorbio Bio-Pharm Recent Developments
  109. 7.19 Lc-Bio Technologies
  110. 7.19.1 Lc-Bio Technologies Company Information
  111. 7.19.2 Lc-Bio Technologies Business Overview
  112. 7.19.3 Lc-Bio Technologies Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Lc-Bio Technologies Modified Proteomics Service Product Portfolio
  114. 7.19.5 Lc-Bio Technologies Recent Developments
  115. 7.20 CD Genomics
  116. 7.20.1 CD Genomics Company Information
  117. 7.20.2 CD Genomics Business Overview
  118. 7.20.3 CD Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 CD Genomics Modified Proteomics Service Product Portfolio
  120. 7.20.5 CD Genomics Recent Developments
  121. 7.21 Discovery Life Sciences
  122. 7.21.1 Discovery Life Sciences Company Information
  123. 7.21.2 Discovery Life Sciences Business Overview
  124. 7.21.3 Discovery Life Sciences Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Discovery Life Sciences Modified Proteomics Service Product Portfolio
  126. 7.21.5 Discovery Life Sciences Recent Developments
  127. 7.22 Applied Biomics
  128. 7.22.1 Applied Biomics Company Information
  129. 7.22.2 Applied Biomics Business Overview
  130. 7.22.3 Applied Biomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Applied Biomics Modified Proteomics Service Product Portfolio
  132. 7.22.5 Applied Biomics Recent Developments
  133. 7.23 VProteomics
  134. 7.23.1 VProteomics Company Information
  135. 7.23.2 VProteomics Business Overview
  136. 7.23.3 VProteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 VProteomics Modified Proteomics Service Product Portfolio
  138. 7.23.5 VProteomics Recent Developments
  139. 7.24 Allumiqs
  140. 7.24.1 Allumiqs Company Information
  141. 7.24.2 Allumiqs Business Overview
  142. 7.24.3 Allumiqs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Allumiqs Modified Proteomics Service Product Portfolio
  144. 7.24.5 Allumiqs Recent Developments
  145. 7.25 Westlake Omics
  146. 7.25.1 Westlake Omics Company Information
  147. 7.25.2 Westlake Omics Business Overview
  148. 7.25.3 Westlake Omics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Westlake Omics Modified Proteomics Service Product Portfolio
  150. 7.25.5 Westlake Omics Recent Developments
  151. 7.26 CDI Labs
  152. 7.26.1 CDI Labs Company Information
  153. 7.26.2 CDI Labs Business Overview
  154. 7.26.3 CDI Labs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  155. 7.26.4 CDI Labs Modified Proteomics Service Product Portfolio
  156. 7.26.5 CDI Labs Recent Developments
  157. 7.27 Proteome Sciences
  158. 7.27.1 Proteome Sciences Company Information
  159. 7.27.2 Proteome Sciences Business Overview
  160. 7.27.3 Proteome Sciences Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Proteome Sciences Modified Proteomics Service Product Portfolio
  162. 7.27.5 Proteome Sciences Recent Developments
  163. 7.28 Sapient Bioanalytics
  164. 7.28.1 Sapient Bioanalytics Company Information
  165. 7.28.2 Sapient Bioanalytics Business Overview
  166. 7.28.3 Sapient Bioanalytics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Sapient Bioanalytics Modified Proteomics Service Product Portfolio
  168. 7.28.5 Sapient Bioanalytics Recent Developments
  169. 7.29 Proteomics International
  170. 7.29.1 Proteomics International Company Information
  171. 7.29.2 Proteomics International Business Overview
  172. 7.29.3 Proteomics International Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Proteomics International Modified Proteomics Service Product Portfolio
  174. 7.29.5 Proteomics International Recent Developments
  175. 7.30 Cosmos Wisdom
  176. 7.30.1 Cosmos Wisdom Company Information
  177. 7.30.2 Cosmos Wisdom Business Overview
  178. 7.30.3 Cosmos Wisdom Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Cosmos Wisdom Modified Proteomics Service Product Portfolio
  180. 7.30.5 Cosmos Wisdom Recent Developments
  181. 7.31 MRM Proteomics
  182. 7.31.1 MRM Proteomics Company Information
  183. 7.31.2 MRM Proteomics Business Overview
  184. 7.31.3 MRM Proteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  185. 7.31.4 MRM Proteomics Modified Proteomics Service Product Portfolio
  186. 7.31.5 MRM Proteomics Recent Developments
  187. 7.32 Sinotech Genomics
  188. 7.32.1 Sinotech Genomics Company Information
  189. 7.32.2 Sinotech Genomics Business Overview
  190. 7.32.3 Sinotech Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Sinotech Genomics Modified Proteomics Service Product Portfolio
  192. 7.32.5 Sinotech Genomics Recent Developments
  193. 7.33 Precision Biomarker Laboratories (PBL)
  194. 7.33.1 Precision Biomarker Laboratories (PBL) Company Information
  195. 7.33.2 Precision Biomarker Laboratories (PBL) Business Overview
  196. 7.33.3 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio
  198. 7.33.5 Precision Biomarker Laboratories (PBL) Recent Developments
  199. 7.34 PTM BIO
  200. 7.34.1 PTM BIO Company Information
  201. 7.34.2 PTM BIO Business Overview
  202. 7.34.3 PTM BIO Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  203. 7.34.4 PTM BIO Modified Proteomics Service Product Portfolio
  204. 7.34.5 PTM BIO Recent Developments
  205. 7.35 Cell Signaling Technology (CST)
  206. 7.35.1 Cell Signaling Technology (CST) Company Information
  207. 7.35.2 Cell Signaling Technology (CST) Business Overview
  208. 7.35.3 Cell Signaling Technology (CST) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio
  210. 7.35.5 Cell Signaling Technology (CST) Recent Developments
  211. 7.36 APTBIO
  212. 7.36.1 APTBIO Company Information
  213. 7.36.2 APTBIO Business Overview
  214. 7.36.3 APTBIO Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  215. 7.36.4 APTBIO Modified Proteomics Service Product Portfolio
  216. 7.36.5 APTBIO Recent Developments
8 North America
  1. 8.1 North America Modified Proteomics Service Revenue (2021-2032)
  2. 8.2 North America Modified Proteomics Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Modified Proteomics Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Modified Proteomics Service Revenue by Type (2027-2032)
  5. 8.3 North America Modified Proteomics Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Modified Proteomics Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Modified Proteomics Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Modified Proteomics Service Revenue by Application (2027-2032)
  9. 8.5 North America Modified Proteomics Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Modified Proteomics Service Revenue by Country
  11. 8.6.1 North America Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Modified Proteomics Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Modified Proteomics Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Modified Proteomics Service Revenue (2021-2032)
  2. 9.2 Europe Modified Proteomics Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Modified Proteomics Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Modified Proteomics Service Revenue by Type (2027-2032)
  5. 9.3 Europe Modified Proteomics Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Modified Proteomics Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Modified Proteomics Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Modified Proteomics Service Revenue by Application (2027-2032)
  9. 9.5 Europe Modified Proteomics Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Modified Proteomics Service Revenue by Country
  11. 9.6.1 Europe Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Modified Proteomics Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Modified Proteomics Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Modified Proteomics Service Revenue (2021-2032)
  2. 10.2 China Modified Proteomics Service Revenue by Type (2021-2032)
  3. 10.2.1 China Modified Proteomics Service Revenue by Type (2021-2026)
  4. 10.2.2 China Modified Proteomics Service Revenue by Type (2027-2032)
  5. 10.3 China Modified Proteomics Service Revenue Share by Type (2021-2032)
  6. 10.4 China Modified Proteomics Service Revenue by Application (2021-2032)
  7. 10.4.1 China Modified Proteomics Service Revenue by Application (2021-2026)
  8. 10.4.2 China Modified Proteomics Service Revenue by Application (2027-2032)
  9. 10.5 China Modified Proteomics Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Modified Proteomics Service Revenue (2021-2032)
  2. 11.2 Asia Modified Proteomics Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Modified Proteomics Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Modified Proteomics Service Revenue by Type (2027-2032)
  5. 11.3 Asia Modified Proteomics Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Modified Proteomics Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Modified Proteomics Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Modified Proteomics Service Revenue by Application (2027-2032)
  9. 11.5 Asia Modified Proteomics Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Modified Proteomics Service Revenue by Country
  11. 11.6.1 Asia Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Modified Proteomics Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Modified Proteomics Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Modified Proteomics Service Revenue (2021-2032)
  2. 12.2 SAMEA Modified Proteomics Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Modified Proteomics Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Modified Proteomics Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Modified Proteomics Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Modified Proteomics Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Modified Proteomics Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Modified Proteomics Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Modified Proteomics Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Modified Proteomics Service Revenue by Country
  11. 12.6.1 SAMEA Modified Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Modified Proteomics Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Modified Proteomics Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst